Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 12 04:00PM ET
1.20
Dollar change
+0.01
Percentage change
0.84
%
Index- P/E- EPS (ttm)-2.15 Insider Own23.56% Shs Outstand11.37M Perf Week0.84%
Market Cap14.51M Forward P/E3.75 EPS next Y0.32 Insider Trans0.00% Shs Float9.24M Perf Month-4.76%
Income-20.39M PEG- EPS next Q-0.32 Inst Own5.91% Short Float6.12% Perf Quarter-30.23%
Sales0.00M P/S- EPS this Y53.58% Inst Trans39.08% Short Ratio3.91 Perf Half Y-65.12%
Book/sh-1.65 P/B- EPS next Y117.24% ROA-231.96% Short Interest0.57M Perf Year-63.08%
Cash/sh0.14 P/C8.79 EPS next 5Y- ROE-682.61% 52W Range1.10 - 7.33 Perf YTD-73.91%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-83.64% Beta1.25
Dividend TTM- Quick Ratio0.20 Sales past 5Y0.00% Gross Margin- 52W Low9.09% ATR (14)0.08
Dividend Ex-Date- Current Ratio0.20 EPS Y/Y TTM57.84% Oper. Margin- RSI (14)42.97 Volatility4.63% 7.36%
Employees- Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price31.67
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q80.01% Payout- Rel Volume0.76 Prev Close1.19
Sales Surprise- EPS Surprise72.97% Sales Q/Q- EarningsNov 18 AMC Avg Volume144.84K Price1.20
SMA20-3.25% SMA50-6.90% SMA200-54.77% Trades Volume124,610 Change0.84%
Nov-26-24 08:03AM
Nov-25-24 08:03AM
Nov-19-24 02:03AM
Nov-18-24 04:05PM
Nov-14-24 04:05PM
08:03AM Loading…
Nov-13-24 08:03AM
Nov-07-24 04:06PM
Oct-31-24 07:00AM
Oct-30-24 07:47AM
Oct-23-24 08:30AM
Oct-12-24 05:18PM
Oct-03-24 06:55AM
Sep-30-24 07:00AM
Sep-11-24 07:55AM
Sep-03-24 07:55AM
07:55AM Loading…
Aug-26-24 07:55AM
Aug-14-24 04:01PM
Aug-13-24 04:01PM
07:30AM
Jul-29-24 08:35AM
08:30AM
Jul-01-24 08:07AM
Jun-28-24 08:07AM
Jun-20-24 08:30AM
Jun-18-24 08:30AM
Jun-10-24 08:30AM
May-28-24 08:30AM
May-14-24 08:57PM
04:01PM
May-08-24 09:55AM
08:30AM Loading…
08:30AM
May-07-24 04:01PM
May-06-24 08:30AM
Apr-30-24 08:30AM
Apr-18-24 08:56AM
08:32AM
08:30AM
Apr-17-24 04:45PM
08:30AM
Apr-15-24 08:30AM
Apr-08-24 08:30AM
Apr-04-24 12:00PM
Apr-02-24 10:33AM
Apr-01-24 08:28AM
Mar-28-24 10:53PM
08:03AM
08:00AM
Mar-26-24 04:03PM
Mar-25-24 08:30AM
Mar-21-24 04:02PM
01:57PM
Mar-18-24 08:30AM
Mar-12-24 07:49AM
Mar-11-24 08:30AM
Mar-04-24 08:30AM
Mar-01-24 08:30AM
Feb-27-24 10:49AM
08:54AM
08:31AM
Feb-26-24 04:01PM
08:30AM
Feb-20-24 08:30AM
Feb-12-24 08:30AM
Feb-09-24 08:30AM
Feb-05-24 06:48AM
Jan-22-24 06:48AM
Jan-17-24 06:48AM
Jan-16-24 06:48AM
Jan-02-24 08:45AM
06:48AM
Dec-27-23 06:48AM
Dec-19-23 08:15AM
Dec-18-23 06:48AM
Dec-13-23 04:02PM
Dec-11-23 06:48AM
Nov-27-23 04:01PM
Nov-16-23 02:07PM
09:32AM
Nov-13-23 06:39PM
Nov-07-23 06:48AM
Nov-06-23 06:48AM
Oct-31-23 06:48AM
Oct-26-23 06:48AM
Oct-12-23 06:48AM
Oct-05-23 06:48AM
Oct-02-23 06:48AM
Sep-21-23 09:35AM
Sep-20-23 06:47AM
Sep-19-23 09:00AM
Sep-18-23 06:46AM
Sep-15-23 06:46AM
Sep-14-23 04:01PM
Sep-07-23 06:47AM
Sep-06-23 10:55AM
Aug-30-23 06:47AM
Aug-29-23 06:54AM
Aug-14-23 04:01PM
Aug-07-23 06:47AM
06:47AM
Jun-20-23 04:01PM
NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.